To support a feasibility study using a bi-partite assay cartridge as a multiplex diagnostic platform for the ultrasensitive detection and quantitation of unamplified nucleic acid targets of influenza A. This innovative system is designed to be compact, fast, and fully automated.
IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
-
Activity
N43
-
Administering IC
AI
-
Application Type
-
Direct Cost Amount
-
Indirect Cost Amount
-
Total Cost
219779
-
Sub Project Total Cost
-
ARRA Funded
False
-
CFDA Code
855
-
Ed Inst. Type
-
Funding ICs
NIAID:219779\
-
Funding Mechanism
SBIR/STTR Contracts
-
Study Section
-
Study Section Name